JOINT FILING AGREEMENT
Exhibit I
This will confirm the agreement by and among the undersigned that the Schedule 13D filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership
by the undersigned of shares of Common Stock, $0.001 par value per share, of BridgeBio Pharma, Inc. is being filed, and all amendments thereto will be filed, on behalf of each of the persons and entities named below that is named as a reporting
person in such filing in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall
constitute one and the same instrument.
Dated: September 17, 2024
|
By: KKR Genetic Disorder GP LLC, its general partner
|
||
|
By:
|
/s/ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇
|
|
|
Name:
|
▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇
|
|
|
Title:
|
Assistant Secretary
|
|
|
KKR GENETIC DISORDER GP LLC
|
||
|
By:
|
/s/ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇
|
|
|
Name:
|
▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇
|
|
|
Title:
|
Assistant Secretary
|
|
|
KKR GROUP PARTNERSHIP L.P.
|
||
|
By: KKR Group Holdings Corp., its general partner
|
||
|
By:
|
/s/ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇
|
|
|
Name:
|
▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇
|
|
|
Title:
|
Secretary
|
|
|
KKR GROUP HOLDINGS CORP.
|
||
|
By:
|
/s/ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇
|
|
|
Name:
|
▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇
|
|
|
Title:
|
Secretary
|
|
|
KKR GROUP CO. INC.
|
||
|
By:
|
/s/ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇
|
|
|
Name:
|
▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇
|
|
|
Title:
|
Secretary
|
|
|
KKR & CO. INC.
|
||
|
By:
|
/s/ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇
|
|
|
Name:
|
▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇
|
|
|
Title:
|
Secretary
|
|
|
KKR MANAGEMENT LLP
|
||
|
By:
|
/s/ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇
|
|
|
Name:
|
▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇
|
|
|
Title:
|
Assistant Secretary
|
|
|
▇▇▇▇▇ ▇. ▇▇▇▇▇▇
|
||
|
By:
|
/s/ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇
|
|
|
Name:
|
▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇
|
|
|
Title:
|
Attorney-in-fact
|
|
|
▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇
|
||
|
By:
|
/s/ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇
|
|
|
Name:
|
▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇
|
|
|
Title:
|
Attorney-in-fact
|
|
2